MedPath

DR. REDDY'S LABORATORIES LIMITED

🇱🇰Sri Lanka
Ownership
-
Employees
-
Market Cap
-
Website

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2010-07-13
Last Posted Date
2010-07-13
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
28
Registration Number
NCT01161147
Locations
🇨🇦

Allied Research International Inc., Mississauga, Ontario, Canada

Bioequivalence Study of Metformin Hydrochloride Tablets 1000 mg Tablets of Dr. Reddy's Laboratories Limited Under Fasting Condition

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2010-07-12
Last Posted Date
2010-07-26
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
54
Registration Number
NCT01160042
Locations
🇮🇳

Vimta Labs Ltd., Hyderabad, Andhra pradesh, India

Bioequivalence Study of Nateglinide Tablets 120 mg of Dr. Reddy's Laboratories Limited Under Fed Condition

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2010-07-12
Last Posted Date
2010-07-13
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
58
Registration Number
NCT01160029

Bioequivalence Study of Metformin Hydrochloride Tablets 1000 mg Tablets of Dr. Reddy's Laboratories Limited Under Fed Condition

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2010-07-12
Last Posted Date
2010-07-13
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
50
Registration Number
NCT01160068
Locations
🇮🇳

Vimta Labs Ltd., Hyderabad, Andhra pradesh, India

Bioequivalence Study of Nateglinide Tablets 120 mg of Dr. Reddy's Laboratories Limited Under Fasting Condition

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2010-07-09
Last Posted Date
2010-07-13
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
68
Registration Number
NCT01159158

Bioavailability Study of Risperidone Orally Disintegrating Tablets 1 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2010-07-02
Last Posted Date
2010-07-02
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
36
Registration Number
NCT01155921

Bioavailability Study of Anastrozole Tablets 1 mg of Dr.Reddy's Under Fed Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2010-07-02
Last Posted Date
2010-07-02
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
36
Registration Number
NCT01155960

Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2010-07-02
Last Posted Date
2010-07-02
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
54
Registration Number
NCT01155895

Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Non-fasting (Fed) Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2010-07-02
Last Posted Date
2010-07-02
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
48
Registration Number
NCT01155908

Bioavailability Study of Anastrozole Tablets 1 mg of Dr.Reddy's Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2010-07-02
Last Posted Date
2010-07-02
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
36
Registration Number
NCT01155947
© Copyright 2025. All Rights Reserved by MedPath